newsfilter
← Latest News
FDA Approved Drugs·

Approval of Xeljanz Xr, Nda #208246 (Labeling)

Approval Date: 09/16/2026; Drug Name: Xeljanz Xr, Nda #208246; Active Ingredients: TOFACITINIB CITRATE; Company: Pfizer; Submission Status: Approval; Submission Classification: Labeling; Application Number: 208246

Company
PFIZER
Keywords
PFIZER